MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 15, 2007; DOI: 10.1124/mol.107.034769


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.034769v1
72/5/1157    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kong, M.
Right arrow Articles by George, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kong, M.
Right arrow Articles by George, S.


Received for publication February 8, 2007.
Revised August 14, 2007.
Accepted for publication August 15, 2007.

REGULATION OF D1 DOPAMINE RECEPTOR TRAFFICKING AND SIGNALING BY CAVEOLIN-1

Michael Kong 1, Ahmed Hasbi 1, Michael Mattocks 1, Theresa Fan 1, Brian O'Dowd 1, Susan George 1*

1 University of Toronto

* Address correspondence to: E-mail: s.george{at}utoronto.ca

Abstract

There is accumulating evidence that G protein-coupled receptor signaling is regulated by localization in lipid raft microdomains. In this report, we determined that the D1 dopamine receptor (D1R) is localized in caveolae, a subset of lipid rafts, by sucrose gradient fractionation and confocal microscopy. Through co-immunoprecipitation and bioluminescence resonance energy transfer assays, we demonstrated that this localization was mediated by an interaction between caveolin-1 and D1R in COS7 cells and an isoform selective interaction between D1R and caveolin-1{alpha}in rat brain. We determined that the D1R interaction with caveolin-1 required a putative caveolin binding motif identified in transmembrane domain 7. Agonist stimulation of D1R caused translocation of D1R into caveolin-1 enriched sucrose fractions which was determined to be a result of D1R endocytosis through caveolae. This was found to be PKA-independent and a kinetically slower process than clathrin mediated endocytosis. Site directed mutagenesis of the caveolin binding motif at amino acids F313 and W318 significantly attenuated caveolar endocytosis of D1R. We also found that these caveolin binding mutants had a diminished capacity to stimulate cAMP production which was determined to be due to constitutive desensitization of these receptors. In contrast, we found that D1Rs had an enhanced ability to maximally generate cAMP in chemically induced caveolae disrupted cells. Taken together, these data suggest that caveolae has an important role in regulating D1R turnover and signaling in brain.


Key words: Dopamine, Gs family, cAMP, Lipid rafts/microdomains, Sequestration/Internalization, Fluorescence techniques, Mutagenesis/Chimeric approaches, Receptor binding studies


This article has been cited by other articles:


Home page
EndocrinologyHome page
F. Xia, L. Xie, A. Mihic, X. Gao, Y. Chen, H. Y. Gaisano, and R. G. Tsushima
Inhibition of Cholesterol Biosynthesis Impairs Insulin Secretion and Voltage-Gated Calcium Channel Function in Pancreatic {beta}-Cells
Endocrinology, October 1, 2008; 149(10): 5136 - 5145.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Ding, R. F. Wiegerinck, M. Shen, A. Cojoc, C. M. Zeidenweber, and M. B. Wagner
Dopamine increases L-type calcium current more in newborn than adult rabbit cardiomyocytes via D1 and {beta}2 receptors
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2327 - H2335.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics